Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H10AsNO5S2.2Na |
| Molecular Weight | 421.232 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].NC(=O)C1=CC=C(C=C1)[As](SCC([O-])=O)SCC([O-])=O
InChI
InChIKey=AXRWJSAOLNNBNI-UHFFFAOYSA-L
InChI=1S/C11H12AsNO5S2.2Na/c13-11(18)7-1-3-8(4-2-7)12(19-5-9(14)15)20-6-10(16)17;;/h1-4H,5-6H2,(H2,13,18)(H,14,15)(H,16,17);;/q;2*+1/p-2
| Molecular Formula | C11H10AsNO5S2 |
| Molecular Weight | 375.252 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Thiacetarsamide is a drug containing trivalent arsenic. In the USA it was used for the treatment of Heartworm Infection in dogs and cats under tradename Caparsolate, however, it was discontinued because of the availability of safer alternatives. The mechanism of action for thiacetarsamide is modulation of glucose uptake and metabolism; inhibition of glutathione reductase, and alteration of the structure and function of the surface of the intestinal epithelium of the parasites.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:26:56 GMT 2025
by
admin
on
Mon Mar 31 18:26:56 GMT 2025
|
| Record UNII |
KW75J7708X
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
||
|
CFR |
21 CFR 522.144
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
14433-82-0
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
PRIMARY | |||
|
SUB10965MIG
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
PRIMARY | |||
|
KW75J7708X
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
PRIMARY | |||
|
72143
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
PRIMARY | |||
|
DTXSID00932291
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
PRIMARY | |||
|
m10711
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
PRIMARY | Merck Index | ||
|
37
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
PRIMARY | |||
|
100000082415
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
PRIMARY | |||
|
C81557
Created by
admin on Mon Mar 31 18:26:56 GMT 2025 , Edited by admin on Mon Mar 31 18:26:56 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |